Ads
related to: ivig treatment for aplastic anemia- How ZILBRYSQ® Works
Find Information On How ZILBRYSQ®
Targets A Key Cause Of Symptoms.
- Self Administration Info
Learn About Self Administration
And ZILBRYSQ® Storage Instructions.
- Patient Resources
Find Brochures, The Self-Injection
Guide And Watch A Training Video.
- View FAQs
Find Answers To Common Questions
You May Have About ZILBRYSQ®.
- Vaccination Requirements
Before Starting Treatment, View The
REMS And Vaccination Requirements.
- Sign Up For Updates
Get Resources, Treatment Support
And Tools To Talk To Your Doctor.
- How ZILBRYSQ® Works
Search results
Results From The WOW.Com Content Network
Aplastic anemia is a rare, noncancerous disorder in which the blood marrow is unable to adequately produce blood cells required for survival. [44] [45] It is estimated that the incidence of aplastic anemia is 0.7–4.1 cases per million people worldwide, with the prevalence between men and women being approximately equal. [46]
The goal is to treat the underlying condition if it can be identified and provide supportive care. If symptomatic anemia develops, blood products may be replaced. Disease specific management may include glucocorticoids, IVIG, immunosuppressive agents, stem cell transplant, or other treatments depending on the etiology of reticulocytopenia. [7]
Anti-thymocyte globulin (ATG) is an infusion of horse or rabbit-derived antibodies against human T cells and their precursors (thymocytes), which is used in the prevention and treatment of acute rejection in organ transplantation and therapy of aplastic anemia due to bone marrow insufficiency.
This is termed "aplastic crisis" (also called reticulocytopenia). It is treated with blood transfusion. Parvovirus B19 is a cause of chronic anemia in individuals with immunodeficiency, receiving immunosuppressive therapy or with HIV infection. Treatment with intravenous immunoglobulin usually resolves the anemia although relapse can occur.
Immunoglobulin therapy is the use of a mixture of antibodies (normal human immunoglobulin) to treat several health conditions. [13] [14] These conditions include primary immunodeficiency, immune thrombocytopenic purpura, chronic inflammatory demyelinating polyneuropathy, Kawasaki disease, certain cases of HIV/AIDS and measles, Guillain–Barré syndrome, and certain other infections when a ...
Pure red cell aplasia affects the red blood cells in particular. Pure red cell aplasia (PRCA) or erythroblastopenia refers to a type of aplastic anemia affecting the precursors to red blood cells but usually not to white blood cells. In PRCA, the bone marrow ceases to produce red blood cells. There are multiple etiologies that can cause PRCA.
Ads
related to: ivig treatment for aplastic anemia